Astrea Bioseparations acquires Delta Precision
Astrea Bioseparations has acquired Delta Precision Ltd, a manufacturer of advanced chromatography columns.
Archives for January 9, 2023
FDA approves licence for anti-amyloid drug to treat Alzheimer's disease
On Friday (Jan 6), the US Food and Drink Administration (FDA) granted a licence for another anti-amyloid drug – lecanemab – to treat Alzheimer’s disease.
ReCode Therapeutics partnering with Bayer's AskBio on single vector gene-editing platform
The collaboration will combine ReCode’s delivery technology with AskBio’s gene editing and DNA cargoes to develop gene correction therapies for liver and lung diseases.
Lonza to support manufacturing of bispecific antibody drug candidate
Lonza and Context Therapeutics are collaborating on the manufacture of a bispecific antibody-based therapy.